Healthy Living: Alzheimer’s Study
5.5 million Americans have Alzheimer’s disease.
Now, in a first-of-its kind trial, researchers are testing a drug they hope will stop the disease in its tracks before damage begins.
Courtney Hunter explains in Health Living.
Researchers are now enrolling participants in ahead 3-45 trials.
They are looking to test antibodies in even younger participants-starting at age 50.
Researchers are also hoping to enroll people interested in Alzheimer’s prevention in the APT web study, which will help screen for future participants.